Long-term Follow-up from Qualitative Interviews of Patients with Relapsed or Refractory Large B-Cell Lymphoma on Their Treatment Experience While Enrolled in a Lisocabtagene Maraleucel Study

被引：0
|
作者：
Barba, Pere [1 ]
Lanar, Sally [2 ]
Liu, Fei Fei [3 ]
Eliason, Laurie [3 ]
Askew, Kshawna [4 ]
Devlen, Jennifer [5 ]
Furustrand, Ulrika [3 ]
Kostic, Ana [3 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Barcelona, Spain
[2] ICON Plc, Lyon, France
[3] Bristol Myers Squibb, Princeton, NJ USA
[4] ICON Plc, Winston Salem, NC USA
[5] ICON Plc, Raleigh, NC USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-178858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Long-term follow-up of patients receiving tositumomab and iodine I 131 tositumomab for recurrent and refractory B-cell lymphoma
    Davies, A
    Howell, S
    Rohatiner, A
    Matthews, J
    Clayton, J
    Massey, T
    Owens, S
    Britton, K
    Radford, J
    Lister, A
    ANNALS OF ONCOLOGY, 2005, 16 : 112 - 112
  • [32] A concise prognostic score system for diffuse large B-cell lymphoma: a retrospective study with long-term follow-up
    Yang, Ying
    Liu, Zhuogang
    Zhang, Guojun
    Wang, Hongtao
    FUTURE ONCOLOGY, 2021, 17 (32) : 4299 - 4306
  • [33] Long-term follow-up of patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed or refractory follicular lymphoma
    Hashida, Risa
    Kato, Jun
    Okamoto, Shinichiro
    Mori, Takehiko
    BONE MARROW TRANSPLANTATION, 2018, 53 : 280 - 281
  • [34] Safety and efficacy results from TRANSCEND NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) in relapsed/refractory large B-cell lymphoma
    Abramson, J.
    Palomba, M. L.
    Gordon, L.
    Lunning, M.
    Wang, M.
    Arnason, J.
    Mehta, A.
    Purev, E.
    Maloney, D.
    Andreadis, C.
    Sehgal, A.
    Solomon, S.
    Ghosh, N.
    Albertson, T.
    Garcia, J.
    Kostic, A.
    Li, D.
    Kim, Y.
    Siddiqi, T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 94 - 95
  • [35] Safety and Efficacy Results From Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (Liso-cel) In Relapsed/refractory Large B-Cell Lymphoma
    Abramson, Jeremy
    Palomba, M. Lia
    Gordon, Leo
    Lunning, Matthew
    Wang, Michael
    Arnason, Jon
    Mehta, Amitkumar
    Purev, Enkhtsetseg
    Maloney, David
    Andreadis, Charalambos
    Sehgal, Alison
    Solomon, Scott
    Ghosh, Nilanjan
    Albertson, Tina
    Garcia, Jacob
    Kostic, Ana
    Li, Daniel
    Kim, Yeonhee
    Siddiqi, Tanya
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 43 - 44
  • [36] COST-EFFECTIVENESS ANALYSIS OF AXICABTAGENE CILOLEUCEL, LISOCABTAGENE MARALEUCEL, AND TISAGENLECLEUCEL CAR T-CELL THERAPIES FOR TREATMENT OF RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA (LBCL)
    Ghanem, B.
    Seoane-Vazquez, E.
    Fleming, M.
    Brown, L. M.
    Rodriguez-Monguio, R.
    VALUE IN HEALTH, 2023, 26 (06) : S75 - S75
  • [37] TRANSCEND: Lisocabtagene Maraleucel (liso-cel; JCAR017) Healthcare Resource Utilization in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
    Palomba, M. Lia
    Garcia, Jacob
    Wang, Lei
    Dehner, Christine
    Chung, Karen C.
    Maloney, David G.
    BLOOD, 2018, 132
  • [38] Lisocabtagene Maraleucel (Liso-Cel) Treatment of Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma and Secondary CNS Lymphoma: Initial Results From TRANSCEND NHL 001
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 19 - 20
  • [39] Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Derenzini, Enrico
    Argnani, Lisa
    Pileri, Stefano
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (04) : 223 - 224
  • [40] Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone
    Cencini, Emanuele
    Rocco, Melania
    Ghio, Francesco
    Simonetti, Federico
    Cuccaro, Annarosa
    De Marco, Federica
    Consoli, Chiara
    Bocchia, Monica
    Fabbri, Alberto
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (02) : 247 - 253
12345